Serum- and HDL3-serum amyloid A and HDL3-LCAT activity are influenced by increased CVD-burden

This study has demonstrated increased SAA-related inflammation in subjects with moderate/significant CVD-burden, which appeared to impact on the antiatherogenic potential of HDL. We suggest that SAA may be a useful biomarker to illustrate increased CVD-burden, although this requires further investigation.